Akebia Therapeutics
AKBA
#7122
Rank
โ‚ฌ0.38 B
Marketcap
1,77ย โ‚ฌ
Share price
2.23%
Change (1 day)
61.93%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2023 (TTM): -0,62ย โ‚ฌ

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -0,62ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,49ย โ‚ฌ an increase over its 2021 EPS that were of -1,64ย โ‚ฌ.

EPS history for Akebia Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,62ย โ‚ฌ25.22%
2022-0,49ย โ‚ฌ-70%
2021-1,64ย โ‚ฌ-38.63%
2020-2,67ย โ‚ฌ17.37%
2019-2,28ย โ‚ฌ2.79%
2018-2,22ย โ‚ฌ31.2%
2017-1,69ย โ‚ฌ-51.39%
2016-3,47ย โ‚ฌ57.89%
2015-2,20ย โ‚ฌ-94.83%
2014-42,56ย โ‚ฌ589.75%
2013-6,17ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
13,65ย โ‚ฌ-2,310.94%๐Ÿ‡บ๐Ÿ‡ธ USA
3,61ย โ‚ฌ-684.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
13,59ย โ‚ฌ-2,300.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,57ย โ‚ฌ 154.69%๐Ÿ‡บ๐Ÿ‡ธ USA